In August 2001, it lost a leading drug when it had to withdraw Lipobay, also called Baycol, and has also had production problems that have hurt sales of its anti-hemophilia drug Kogenate.
Bleeding Disorders Treatment Market Size & Growth Analysis: “According to SNS Insider, The Bleeding Disorders Treatment Market Size was valued at USD 16.35 billion in 2023 and is expected to attain a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results